The Medicine Shoppe

The vendor opportunity at The Medicine Shoppe

The Medicine Shoppe is a pharmacy franchise brand owned by Cardinal Health, Inc., a major player in pharmaceutical and specialty distribution. According to the 2025 Franchise Disclosure Document, the system comprises 271 franchised units. Company-owned unit counts are not disclosed. The franchise footprint is concentrated in Pennsylvania (56 units), California (41), Maryland (24), Illinois (21), and Kentucky (20). Year-over-year unit growth declined by 7.192%, a contraction that software vendors should factor into their total addressable market calculations. Average unit volume is not disclosed in the FDD. The royalty rate is 3.0% of gross sales, and the initial franchise term is 5 years.

Who controls software purchasing

Purchasing authority sits at the franchisor level, specifically within Cardinal Health’s management structure. The FDD lists Brad Cochran as President of MSI, Medicap and Cardinal Health Executive Vice President, Pharmaceutical and Specialty Distribution. John Anthony (Tony) Steiner serves as Vice President, MSI and Medicap, and National Vice President, Programs and Solutions at Cardinal Health — a role directly relevant to technology and program vendors. Julie V. Wilson is Director, Marketing Management for MSI and Medicap and Cardinal Health. Cornelius T. Lane, III is Director of Franchise Development. These are the individuals most likely to evaluate or approve software that touches pharmacy operations, marketing, or compliance. The operator base includes 279 single-unit franchisees and 32 multi-unit operators (2–9 units each). No franchisee operates 10 or more units, meaning purchasing influence is heavily centralized at HQ.

Mandated and current tech stack

The 2025 FDD mandates two specific technology programs. Cardinal Health™ Pharmacy Marketing Advantage is a marketing platform tied to the parent company’s distribution ecosystem. The EQuIPP Program is a pharmacy performance measurement and quality improvement platform. No other mandated POS, PMS, or operational software is disclosed in the FDD. Vendors offering complementary or replacement solutions in pharmacy management, inventory, compliance, or patient engagement should understand that any new technology must integrate with or gain approval alongside these existing Cardinal Health-aligned systems.

Procurement, renewals, and timing

Item 8 of the FDD does not provide an extract describing the procurement model. Whether The Medicine Shoppe requires franchisees to purchase from designated suppliers, approved suppliers, or allows open purchasing is not disclosed in the available data. Franchise agreements automatically renew for additional 5-year terms unless either party provides written notice of non-renewal at least six months before expiration. Renewal is conditioned on signing the then-current form of franchise agreement. This creates a predictable cycle: vendors can map renewal cohorts by working backward from unit opening dates and the 5-year term, targeting engagement 12–18 months before a renewal window to align with budget planning.

How to read the The Medicine Shoppe FDD

The 2025 FDD is embedded below. It contains the legal and operational disclosures filed with state franchise regulators. Software vendors should focus on Item 11 (franchisor’s obligations) for technology mandates, Item 8 (restrictions on sources of products and services) for procurement rules, and Item 17 (renewal, termination, transfer) for contract cycle intelligence. The executive team listed in Item 1 identifies the buying center. Use this document to validate the facts above and build a precise account plan before outreach.

For a ranked target list of franchise systems matched to your software category, FranCloud can help.